跳至主要内容
临床试验/IRCT20160215026563N2
IRCT20160215026563N2招募中2 期

investigation of the therapeutic effects of intralesional injection of Nimodipine on the treatment of resistant cases of cutaneous leishmaniasis

Mashhad University of Medical Sciences0 个研究点目标入组 17 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
17

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Age more than 18 years;
  • maximum lesion number is 4;
  • duration of illness is less than one year;
  • lesion type is dry Leishmaniasis (Clinical manifestation of urban leishmaniasis);
  • There are no sings of lymphangitis and sporotrichoid;
  • No more than 2 months has passed from the incidence of the lesion until wound formation;
  • there is no widespread wound and secretion.

排除标准

  • having other atypical forms such as lupoid-sporotrichoid-erysipeloid-zoster forms and....;
  • patients who have had a heart attack within the last month;
  • patients with unstable angina;
  • patients with less than 100 spontaneous bacterial peritonitis (SBP) and consuming medications such as Azoles and Sodium Vauproat, and Macrolide and Fluoxetine due to the prohibition of Nimodipine use in these people;
  • incidence of drug complications during treatment such as Phlebitis, hypotension, headache, severe nausea and vomiting;
  • breastfeeding;
  • the lesion is preferably not on the face.

研究者

相似试验